Finally, Hirvonen et al. (2011) reported that brain glucose metabolism as assessed by 18FDG-PET increased in subjects with impaired glucose tolerance during a hyperinsulinemic-euglycemic clamp but not in healthy subjects, in whom the effect of insulin on brain glucose metabolism appeared to be saturated at fasting levels of insulin. The gene discussed is INS; the disease is Impaired glucose tolerance.